Savara, Inc. (SVRA)
5.78
+0.14
(+2.48%)
USD |
NASDAQ |
Apr 17, 16:00
5.765
-0.02
(-0.26%)
After-Hours: 20:00
Savara SG&A Expense (Quarterly) : 12.53M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Spyre Therapeutics, Inc. | 12.53M |
| ACADIA Pharmaceuticals, Inc. | 155.62M |
| Alnylam Pharmaceuticals, Inc. | 325.37M |
| BioMarin Pharmaceutical, Inc. | 446.21M |
| Imunon, Inc. | 1.772M |